[1]
Yang C,Montgomery M, Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews. 2021 Mar 18 [PubMed PMID: 33735508]
[2]
Dentice R,Elkins M, Timing of dornase alfa inhalation for cystic fibrosis. The Cochrane database of systematic reviews. 2021 Mar 9 [PubMed PMID: 33686652]
[3]
Yang C,Montgomery M, Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews. 2018 Sep 6; [PubMed PMID: 30187450]
[4]
Bobek V,Majewski A,Kolostova K,Rzechonek A,Lischke R,Schutzner J,Kacprzak G, Intrapleural administration of DNase alone for pleural empyema. International journal of clinical and experimental medicine. 2015; [PubMed PMID: 26885174]
[5]
Torbic H,Hacobian G, Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center. Journal of pharmacy practice. 2016 Oct; [PubMed PMID: 25667210]
[6]
Scala M,Hoy D,Bautista M,Palafoutas JJ,Abubakar K, Pilot study of dornase alfa (Pulmozyme) therapy for acquired ventilator-associated infection in preterm infants. Pediatric pulmonology. 2017 Jun; [PubMed PMID: 28052587]
[7]
Barnes BJ,Adrover JM,Baxter-Stoltzfus A,Borczuk A,Cools-Lartigue J,Crawford JM,Daßler-Plenker J,Guerci P,Huynh C,Knight JS,Loda M,Looney MR,McAllister F,Rayes R,Renaud S,Rousseau S,Salvatore S,Schwartz RE,Spicer JD,Yost CC,Weber A,Zuo Y,Egeblad M, Targeting potential drivers of COVID-19: Neutrophil extracellular traps. The Journal of experimental medicine. 2020 Jun 1 [PubMed PMID: 32302401]
[8]
Nasr SZ,Kuhns LR,Brown RW,Hurwitz ME,Sanders GM,Strouse PJ, Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Pediatric pulmonology. 2001 May; [PubMed PMID: 11340684]
[9]
Mogayzel PJ Jr,Naureckas ET,Robinson KA,Mueller G,Hadjiliadis D,Hoag JB,Lubsch L,Hazle L,Sabadosa K,Marshall B, Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. American journal of respiratory and critical care medicine. 2013 Apr 1; [PubMed PMID: 23540878]
[10]
Bryson HM,Sorkin EM, Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs. 1994 Dec; [PubMed PMID: 7533697]
[12]
Witt DM,Anderson L, Dornase alfa: a new option in the management of cystic fibrosis. Pharmacotherapy. 1996 Jan-Feb; [PubMed PMID: 8700791]
[13]
Moore BM,Laguna TA,Liu M,McNamara JJ, Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1. Pediatric pulmonology. 2013 Aug; [PubMed PMID: 22997186]